Costa NA, Kshirsagar AV, Wang L, Detwiler RK, Brookhart MA. Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation. 2013;96(9):807–13.PubMedCentralCrossRefPubMed

Dauru M, et al. Combined general and epidural anesthesia with ropivacaine for renal transplantation. Minerva Anestesiol. 2003;69:873–84.

Nicholls AJ, Tucker V, Gibbs P. Awake renal transplantation; a realistic alternative to general anesthesia. Transplant Proc. 2010;42:1677–8.CrossRefPubMed

Schmid S, Jungwirth B. Anaesthesia for renal transplant surgery: an update. Eur J Anaesthesiol. 2012;29:552–8.CrossRefPubMed

Niscola P, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010;11(6):752–8.CrossRefPubMed

Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care. 2005;33(3):311–22.PubMed

Fahey MR, Rupp SM, Fisher DM, et al. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology. 1984;61:699–702.CrossRefPubMed

Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide(Org 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth. 1993;71:222–6.CrossRefPubMed

Teixeira S, Costa G, Costa F, da Silva VJ, Mota A. Sevoflurane versus isoflurane: does it matter in renal transplantation? Transplant Proc. 2007;39(8):2486–8.CrossRefPubMed

Guay J. The benefits of adding epidural analgesia to general anesthesia: a metaanalysis. J Anesth. 2006;20:335–40.CrossRefPubMed

Hansen TG. Ropivacaine: a pharmacological review. Expert Rev Neurother. 2004;4(5):781–91.CrossRefPubMed

Foster RH, Markham A. Levobupivacaine: a review of its pharmacology and use as a local anaesthetic. Drugs. 2000;59(3):551–79.CrossRefPubMed